Results 21 to 30 of about 111,076 (331)

The role of CD24 as a potential biomarker for malignant pleural mesothelioma

open access: yesEgyptian Journal of Chest Disease and Tuberculosis, 2023
Objectives Pleural mesothelioma is a rapidly progressing pleural neoplasm caused by asbestos exposure of a long latency around 30-40 years. Patients with mesothelioma are usually diagnosed at a late stage with poor outcomes in terms of morbidity and ...
Mohamed Shaaban Mousa   +4 more
doaj   +1 more source

Pleural mesothelioma and lung cancer risks in relation to occupational history and asbestos lung burden. [PDF]

open access: yes, 2015
BACKGROUND: We have conducted a population-based study of pleural mesothelioma patients with occupational histories and measured asbestos lung burdens in occupationally exposed workers and in the general population.
Burdett, G   +9 more
core   +2 more sources

Malignant mesothelioma [PDF]

open access: yesOrphanet Journal of Rare Diseases, 2008
Malignant mesothelioma is a fatal asbestos-associated malignancy originating from the lining cells (mesothelium) of the pleural and peritoneal cavities, as well as the pericardium and the tunica vaginalis. The exact prevalence is unknown but it is estimated that mesotheliomas represent less than 1% of all cancers.
Parker Robert J   +2 more
openaire   +3 more sources

Estimated future incidence of malignant mesothelioma in South Korea: Projection from 2014 to 2033. [PDF]

open access: yesPLoS ONE, 2017
Malignant mesothelioma is a malignant tumor on the pleura or the peritoneum caused mostly by asbestos. Although asbestos is not currently used in South Korea, the incidence of mesothelioma is increasing due to its long latent period. This study predicted
Kyeong Min Kwak   +3 more
doaj   +1 more source

Recommendations for improving follow-up care for patients with mesothelioma: a qualitative study comprising documentary analysis, interviews and consultation meetings

open access: yesBMJ Open, 2021
Objectives The study aim was to explore experiences of patients with pleural mesothelioma of follow-up care in three National Health Service (NHS) Trusts to develop recommendations for practice.Design The study design was qualitative and comprised three ...
Najib Rahman   +6 more
doaj   +1 more source

Genomic profiling of malignant peritoneal mesothelioma reveals recurrent alterations in epigenetic regulatory genes BAP1, SETD2, and DDX3X. [PDF]

open access: yes, 2017
Malignant mesothelioma is a rare cancer that arises from the mesothelial cells that line the pleural cavity and less commonly from the peritoneal lining of the abdomen and pelvis.
Bastian, Boris C   +10 more
core   +2 more sources

Asbestos Consumption and Malignant Mesothelioma Mortality Trends in the Major User Countries

open access: yesAnnals of Global Health, 2023
Background: The causal association between mesothelioma and asbestos exposure is conclusive, and many studies have proved that the trend in asbestos use is a strong predictor of the pattern in mesothelioma cases with an adequate latency time (generally ...
Claudio Gariazzo   +2 more
doaj   +1 more source

An Unusual Cause of Abdominal Ascites. [PDF]

open access: yes, 2018
Abdominal ascites is most commonly caused by portal hypertension from liver cirrhosis. When present, portal hypertension is associated with an elevated serum-ascites albumin gradient (SAAG) ≥1.1 g/dL. In contrast, a SAAG < 1.1 g/dL suggests malignancy,
Chak, Eric W   +2 more
core   +2 more sources

Breast cancer or metastasis? An unusual case of metastatic malignant pleural mesothelioma to the breast [PDF]

open access: yes, 2015
Background: Metastases to the breast from extramammary malignancies are very rare, and ruling out the diagnosis of primary breast tumor is important in order to decide on clinical management and predict prognosis.
Derme, Martina   +5 more
core   +2 more sources

The development and characterization of a human mesothelioma in vitro 3D model to investigate immunotoxin therapy. [PDF]

open access: yes, 2011
BackgroundTumor microenvironments present significant barriers to penetration by antibodies and immunoconjugates. Tumor microenvironments, however, are difficult to study in vitro.
Broaddus, V Courtney   +8 more
core   +3 more sources

Home - About - Disclaimer - Privacy